Intravitreal Injection of Tissue Plasminogen Activator as Treatment for an Occluded Pars Plana Glaucoma Tube

Clinical Ophthalmology - New Zealand
doi 10.2147/opth.s3831
Full Text
Abstract

Available in full text

Categories
Ophthalmology
Date
Authors
Publisher

Informa UK Limited

Related search

Pars Plana Vitrectomy With Pars Plana Tube Implantation in Eyes With Intractable Glaucoma

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
1998English

Baerveldt or Ahmed Glaucoma Valve Implantation With Pars Plana Tube Insertion in Japanese Eyes With Neovascular Glaucoma: 1-Year Outcomes

Clinical Ophthalmology
Ophthalmology
2018English

Anterior Segment Changes Following Intravitreal Bevacizumab Injection for Treatment of Neovascular Glaucoma

Clinical Ophthalmology
Ophthalmology
2011English

Low-Dose Tissue Plasminogen Activator for Calciphylaxis

Archives of Dermatology
2004English

Tissue Plasminogen Activator Therapy for the Eye

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2005English

4766075 Human Tissue Plasminogen Activator

Biotechnology Advances
Applied MicrobiologyBiotechnologyBioengineering
1989English

Efficacy of Intravitreal Injection of Tissue Plasminogen Activator on Improvement of Visual Acuity and Decreasing the Rate of Complications in Retinal Vein Occlusion

Journal of Clinical & Experimental Ophthalmology
2012English

Tissue Plasminogen Activator-Based Nanothrombolysis for Ischemic Stroke

Expert Opinion on Drug Delivery
Pharmaceutical Science
2017English

Pars Plana Vitrectomy for Vitreous Floaters

Retina
MedicineOphthalmology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy